The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […] …read more […]
Before you buy the dip in the markets in the latter stages of September, consider these key risks on the plate for October. …read more […]
Stocks on the move: Virgin Galactic on BOA buy rating, Pinterest as Guggenheim initiates coverage w/ buy rating . …read more […]
Today we’re going to take a look at the well-established Okta, Inc. (NASDAQ:OKTA). The company’s stock saw a… …read more […]
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […] …read more […]
If you really want to know which stocks the experts – and those in the know – are buying, pay attention to what they’re doing. Stock reports, company reviews, and press statements are helpful, but you’ll get significant information from watching what the insiders are up to.The insiders – the corporate officers and board members – have to disclose when they snap up shares to prevent any unfair advantages. Tracking their stock purchases can be a useful strategy because if an insider spends their own money on a stock, it could signal that they believe big gains are in store.So, …read more […]
Yahoo Finance’s Akiko Fujita breaks down the stocks to watch Monday. …read more […]
Winning the presidency in 2016 has brought Trump intense scrutiny that could end up undoing him. …read more […]
Morgan Stanley Analyst Adam Jonas joins the On the Move panel to discuss the latest with Tesla, and why its China sales may be non-existent by 2030. …read more […]
Many popular online high-yield savings accounts used to have really good rates, but they’ve been slashed significantly. Here’s what to do to maximize your rates. …read more […]
What is margin trading for new investors in the stock market? And, is it the right strategy for you? There are many ways to make money by trading stocks and creating margin accounts is certainly one opportunity.
However, what is it and how does it work? Let’s take a deeper dive into this unique trading strategy below.
What is Margin Trading for Beginners?
Are you looking to boost or enhance your gains in the stock market? And are you willing to take on larger risks? If so, trading on “margin” may be right up your alley.
So, what is margin trading to be exact? …read more […]
If you are looking for the best ideas for your portfolio you may want to consider some of VGI Partners top stock picks. VGI Partners, an investment management firm, is bullish on CME Group Inc. (NASDAQ:CME) stock. In its FY 2019 investor letter – you can download a copy here – the firm discussed its […] …read more […]
Tom Essaye, Sevens Report Research Founder, joins Yahoo Finance’s The First Trade with Alexis Christoforous and Brian Sozzi to discuss what’s moving the markets on Monday morning. …read more […]
Mat Ishbia, United Wholesale Mortgage CEO, joins Yahoo Finance’s The First Trade with Alexis Christoforous and Brian Sozzi to discuss the company’s plans to go public through a SPAC transaction with Gore Holdings valued at $16.1 billion dollars, the importance of team culture, future outlook, and much more. …read more […]
Sorrento Therapeutics (SRNE) has taken a unique approach to fighting the coronavirus. While most pharma companies taking the good fight to COVID-19 have focused their energies on one area, Sorrento has taken a more scatter gun approach. The biotech is developing a COVID-19 vaccine, a diagnostic test, an antibody test and has several therapeutic candidates.While it remains to be seen whether the varied method pays off, Dawson James analyst Jason Kolbert believes Sorrento might have a fan, who as they say, has some influence in high places.During a presidential press conference, “the president mentioned among promising therapeutics a monoclonal-antibody that …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
